Showing results (301-310 of 548) with videos related to

Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|April 2, 2021
Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medicationMiriam Larsen-Barr, Fred Seymour
Therapeutic Advances in Psychopharmacology|April 2, 2021
Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort studyJessica Spokes, Samantha Hollingworth, Karl Winckel, et al.
Therapeutic Advances in Psychopharmacology|April 2, 2021
Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorderMutahira M Qureshi, Allan H Young
Therapeutic Advances in Psychopharmacology|July 31, 2020
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapineSiobhan Gee, David Taylor
Therapeutic Advances in Psychopharmacology|March 30, 2023
Second to none: rationale, timing, and clinical management of clozapine use in schizophreniaMishal Qubad, Robert A Bittner
Therapeutic Advances in Psychopharmacology|July 24, 2020
How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medicationPeter C Groot, Jim van Os
Therapeutic Advances in Psychopharmacology|August 29, 2013
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?James M Stone
Therapeutic Advances in Psychopharmacology|August 29, 2013
A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depressionUlla Knorr, Maj Vinberg, Anders Gade, et al.
Pageof 55